The Ankle-Brachial Index has become an important tool in diagnosing Peripheral Arterial Disease (PAD). This is especially due to its digital nature, simple use, cost-effectiveness and speed compared to the traditional diagnostic tool for PAD: Doppler ultrasound. After the ABI check-up, Doppler can serve as a final step towards the PAD diagnosis.
The MESI ABPI MD is the basic, but world’s fastest ABI measurement tool. The MESI mTABLET ABI, however, is an advanced solution for combining ABI with other diagnostic measurements on one device.
In this blog you will learn:
The importance of PAD screening with ABI is stressed by major recent guidelines such as the American Heart Association Scientific Statement from 2021, which urges for it to be implemented for all risk groups. The ABI measurement is regarded as the first step towards PAD diagnosis and thus successful PAD management.
The usefulness of the Ankle-Brachial Index measurement is also recommended by scientific studies that have tested it in comparison to Doppler. Hageman et al. describes automated ABI as “a simple, fast, and fully automatic test that is increasingly proposed in primary care settings as it has advantages compared with Doppler regarding equipment, training, and time constraints.” 
ABI measurement is recommended in the following fields:
MESI was established with the aim to simplify diagnostics. Battling underdiagnosed Peripheral Arterial Disease was our initial primary mission. The mission evolved throughout the years, but timely arterial assessment is and will always be one of our main focuses.
We want every single patient at risk of PAD to be diagnosed. The MESI portfolio includes a basic and a smart version of the Ankle-Brachial Index.
The world’s fastest Ankle-Brachial Index tool, the MESI ABPI MD, was the first product of the MESI company. After it ruled its segment for a decade, we are now presenting a brand new edition of the MESI ABPI MD. It fits seamlessly into a modern medical practice while staying true to its basic ease-of-use roots.
The ‘old’ MESI ABPI MD device has been discontinued, but its servicing and maintenance will still be supported.
Like its original version, MESI ABPI MD is intended for single ABI measurements. It offers one-button operation to be as staff-friendly as possible. Here are its most important highlights:
SPEED WITH SmartArm™ DETECTION
No need for rest time. Regulated cuff inflation and deflation in 1 minute. Automatic detection of the arm with higher blood pressure.
RELIABILITY WITH 3CUFF™ TECHNOLOGY
Simultaneous, risk-free measurement eliminating human error and blood pressure drift.
ACCURACY WITH PADsense™ ALGORITHM
Reliable automatic interpretation of the pulse waveform to identify severe disease and notify the operator with a clear ‘PAD’ message.
DETAIL WITH MESIresults SOFTWARE
Report review, report print-out and storing of the results for a precise interpretation at any time.
RESULTS AND INTERPRETATION
Unlimited online storage of measurement results.
MESI ABPI MD is a stand-alone device offering single ABI measurements.
The MESI mTABLET ABI is a smart device offering not only ABI measurement, but also the benefits of comprehensive arterial assessment and full digital workflow at your medical practice or home visits. This is due to the MESI mTABLET digital system with the following advantages:
Get in touch with us!